Pain
FDA/CDC
Califf plans work on opioids, accelerated approvals on return to FDA
In emphasizing the need for continued efforts to address risks of painkillers, Biden’s FDA nominee cites his relatives’ experience in getting 30-...
News
Are newer migraine therapies better? It depends
“Triptans will be around for a long time, but the newer medications are here to stay,”
News
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
Latest News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
FDA/CDC
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
FDA/CDC
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
News
‘Alarming’ increase in fake pills laced with fentanyl, methamphetamine, DEA warns
More than 9.5 million fake pills have been seized so far this year – more than the last 2 years combined.
Conference Coverage
Growing proportion of cardiac arrests in U.S. considered opioid related
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.
Conference Coverage
‘Lopioid protocol’ – low-dose opioids – proposed for fracture surgery
“Managing narcotics postoperatively can be challenging due to the fact that many people come into these fractures with a history of narcotic use...
News
‘Deeper dive’ into opioid overdose deaths during COVID pandemic
Results also showed that, compared to 2019, significantly more men died from overdoses in 2020 in Colorado and Indiana.